- PLVAP in diabetic retinopathy: A gatekeeper of angiogenesis and vascular permeability
C.J.F. van Noorden
- Award date
- 28 October 2014
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
Nowadays, approximately 4 million people worldwide experience blindness or severe vision loss caused by diabetic retinopathy. Diabetic retinopathy is a multifactorial disease that can progress from minor changes in vascular permeability, into a proliferative retinal disorder. The increasing incidence of diabetes diagnosis and lack of effective treatments make the development of new therapies an urgent issue. Previous studies have reported increased plasmalemma vesicle-associated protein (PLVAP) expression in the retinal vasculature of diabetic retinopathy patients, which co-localized with vascular permeability. In this thesis, the role of PLVAP in development and progression of diabetic retinopathy is explored. The performed in vitro and in vivo research revealed the key role of PLVAP in regulating Vascular Endothelial Growth Factor (VEGF)-induced angiogenesis and increased vascular permeability. This makes PLVAP an interesting, endothelial cell-specific therapeutic target for diabetic retinopathy.
- Research conducted at: Universiteit van Amsterdam
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.